{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "7713019", "DateCompleted": {"Year": "1995", "Month": "05", "Day": "16"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0091-6765", "JournalIssue": {"Volume": "102", "Issue": "12", "PubDate": {"Year": "1994", "Month": "Dec"}}, "Title": "Environmental health perspectives", "ISOAbbreviation": "Environ Health Perspect"}, "ArticleTitle": "Modulation of bronchial epithelial cell barrier function by in vitro ozone exposure.", "Pagination": {"StartPage": "1068", "EndPage": "1072", "MedlinePgn": "1068-72"}, "Abstract": {"AbstractText": ["The epithelial cells lining the small, peripheral airways function as important targets for the action of inspired ozone. Loss of epithelial barrier integrity in these regions is a common element in ozone-induced airway inflammation. To investigate the direct effect of ozone on epithelial barrier function, canine bronchial epithelial (CBE) cells grown with an air interface were exposed for 3 hr to 0.2, 0.5, or 0.8 ppm ozone or to air. Mannitol flux, used as an index of paracellular permeability, increased above air controls by 461%, 774%, and 1172% at the three ozone concentrations, respectively. Transcellular electrical resistance exhibited a dose-related decrease. The immediate effect of 0.8 ppm ozone on permeability was significantly inhibited by preincubation for 48 hr in the presence of 1 ng/ml vitamin E (33%) or 1 microM vitamin A (34%). Responses to 0.5 ppm or 0.8 ppm were inhibited by pretreatment of the cells with 0.1 microM of the actin polymerizing agent phalloidin (34% and 25% inhibition, respectively). The increases in permeability induced by 0.2 and 0.5 ppm ozone were attenuated by 54% and 22%, respectively, at 18 hr after exposure, whereas that to 0.8 ppm was further enhanced by 42% at this time. The effects of ozone are modulated by the availability of antioxidants to the cells and appear to be associated with cytoskeletal dysfunction in CBE cells. The data are consistent with a loss of barrier function linked to a direct oxidative effect of ozone on individual CBE cells and indicate that the reversible or progressive nature of this effect is dose dependent."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental Health Sciences, Johns Hopkins School of Hygiene and Public Health, Baltimore, MD 21205."}], "Identifier": [], "LastName": "Yu", "ForeName": "X Y", "Initials": "XY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Takahashi", "ForeName": "N", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Croxton", "ForeName": "T L", "Initials": "TL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Spannhake", "ForeName": "E W", "Initials": "EW"}], "GrantList": [{"GrantID": "ES 03505", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "ES 03819", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Environ Health Perspect", "NlmUniqueID": "0330411", "ISSNLinking": "0091-6765"}, "ChemicalList": [{"RegistryNumber": "11103-57-4", "NameOfSubstance": "Vitamin A"}, {"RegistryNumber": "1406-18-4", "NameOfSubstance": "Vitamin E"}, {"RegistryNumber": "17466-45-4", "NameOfSubstance": "Phalloidine"}, {"RegistryNumber": "3CHI920QS7", "NameOfSubstance": "Cytochalasin B"}, {"RegistryNumber": "3OWL53L36A", "NameOfSubstance": "Mannitol"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Bronchi"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Membrane Permeability"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["administration & dosage", "metabolism"], "DescriptorName": "Cytochalasin B"}, {"QualifierName": [], "DescriptorName": "Dogs"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Epithelium"}, {"QualifierName": [], "DescriptorName": "Fluorescence"}, {"QualifierName": ["administration & dosage", "metabolism"], "DescriptorName": "Mannitol"}, {"QualifierName": ["pharmacokinetics", "pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["administration & dosage", "metabolism"], "DescriptorName": "Phalloidine"}, {"QualifierName": ["administration & dosage", "metabolism"], "DescriptorName": "Vitamin A"}, {"QualifierName": ["administration & dosage", "metabolism"], "DescriptorName": "Vitamin E"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Free Radic Biol Med. 1990;9(3):245-65", "ArticleIdList": ["2272533"]}, {"Citation": "Am J Respir Cell Mol Biol. 1991 Jan;4(1):72-81", "ArticleIdList": ["1846079"]}, {"Citation": "Chest. 1992 Mar;101(3 Suppl):22S", "ArticleIdList": ["1541192"]}, {"Citation": "J Appl Physiol (1985). 1992 Feb;72(2):670-6", "ArticleIdList": ["1559947"]}, {"Citation": "Fundam Appl Toxicol. 1992 Feb;18(2):175-80", "ArticleIdList": ["1601217"]}, {"Citation": "Toxicol Appl Pharmacol. 1992 Jun;114(2):268-76", "ArticleIdList": ["1609419"]}, {"Citation": "Am J Respir Cell Mol Biol. 1992 Nov;7(5):514-22", "ArticleIdList": ["1419027"]}, {"Citation": "Arch Biochem Biophys. 1993 Apr;302(1):103-8", "ArticleIdList": ["8470886"]}, {"Citation": "Am J Physiol. 1993 Jul;265(1 Pt 1):L33-7", "ArticleIdList": ["8338179"]}, {"Citation": "Environ Health Perspect. 1993 Jun;101(2):154-64", "ArticleIdList": ["8354202"]}, {"Citation": "Am J Respir Cell Mol Biol. 1994 Aug;11(2):188-98", "ArticleIdList": ["8049079"]}, {"Citation": "Am Rev Respir Dis. 1978 Dec;118(6):1061-90", "ArticleIdList": ["369411"]}, {"Citation": "Biochim Biophys Acta. 1981 May 22;664(2):266-72", "ArticleIdList": ["7248325"]}, {"Citation": "Circ Res. 1982 Nov;51(5):657-61", "ArticleIdList": ["6890416"]}, {"Citation": "Am Rev Respir Dis. 1984 Feb;129(2):288-91", "ArticleIdList": ["6696327"]}, {"Citation": "Virchows Arch B Cell Pathol Incl Mol Pathol. 1984;45(2):197-219", "ArticleIdList": ["6143447"]}, {"Citation": "Am Rev Respir Dis. 1986 Jul;134(1):17-21", "ArticleIdList": ["2425672"]}, {"Citation": "Am Rev Respir Dis. 1986 Sep;134(3):572-9", "ArticleIdList": ["3530074"]}, {"Citation": "Toxicol Lett. 1987 Feb;35(2-3):315-9", "ArticleIdList": ["2435024"]}, {"Citation": "Int J Pept Protein Res. 1987 May;29(5):621-8", "ArticleIdList": ["2886443"]}, {"Citation": "J Cell Biol. 1987 Oct;105(4):1473-8", "ArticleIdList": ["3312229"]}, {"Citation": "Exp Mol Pathol. 1987 Dec;47(3):327-45", "ArticleIdList": ["3678465"]}, {"Citation": "Microvasc Res. 1988 May;35(3):308-15", "ArticleIdList": ["3393092"]}, {"Citation": "J Appl Physiol (1985). 1988 Jul;65(1):393-400", "ArticleIdList": ["3403482"]}, {"Citation": "J Neurochem. 1989 Feb;52(2):585-8", "ArticleIdList": ["2911031"]}, {"Citation": "Lung. 1988;166(6):355-69", "ArticleIdList": ["3148794"]}, {"Citation": "Exp Lung Res. 1989 Mar;15(2):253-68", "ArticleIdList": ["2707184"]}, {"Citation": "Am J Respir Cell Mol Biol. 1990 Aug;3(2):119-29", "ArticleIdList": ["2378746"]}, {"Citation": "J Toxicol Environ Health. 1990 Aug;30(4):287-304", "ArticleIdList": ["2388300"]}, {"Citation": "Toxicol Appl Pharmacol. 1992 Jan;112(1):64-72", "ArticleIdList": ["1733049"]}]}], "History": [{"Year": "1994", "Month": "12", "Day": "1"}, {"Year": "1994", "Month": "12", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1994", "Month": "12", "Day": "1", "Hour": "0", "Minute": "0"}, {"Year": "1994", "Month": "12", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["7713019", "PMC1567478", "10.1289/ehp.941021068"]}}], "PubmedBookArticle": []}